CLDX icon

Celldex Therapeutics

129 hedge funds and large institutions have $204M invested in Celldex Therapeutics in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 17 closing their positions.

Holders
129
Holders Change
-1
Holders Change %
-0.77%
% of All Funds
3.22%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
18
Increased
44
Reduced
30
Closed
17
Calls
$904K
Puts
$837K
Net Calls
+$67K
Net Calls Change
+$288K
Name Market Value Shares Shares
Change
Shares
Change %
ASN
126
Advisory Services Network
Georgia
$1K 260
AIM
127
Advantage Investment Management
Iowa
$1K 500
ECM
128
Estabrook Capital Management
New York
$309 108
CCMH
129
Cornerstone Capital Management Holdings
New York
-105,817 Closed
MC
130
Marcus Capital
Illinois
-103,800 Closed
NIT
131
NumerixS Investment Technologies
British Columbia, Canada
-60,540 Closed
GC
132
Guggenheim Capital
Illinois
-18,528 Closed
SIA
133
Sit Investment Associates
Minnesota
-14,750 Closed
Simplex Trading
134
Simplex Trading
Illinois
-14,420 Closed
Franklin Resources
135
Franklin Resources
California
-12,434 Closed
CAN
136
Cetera Advisor Networks
California
-10,883 Closed
FMT
137
First Mercantile Trust
Tennessee
-9,996 Closed
MLFP
138
MPS Loria Financial Planners
Illinois
-7,250 Closed
PSUF
139
People's United Financial
Connecticut
-1,245 Closed
MAM
140
Meeder Asset Management
Ohio
-951 Closed
CPIG
141
Chicago Partners Investment Group
Illinois
-482 Closed
US Bancorp
142
US Bancorp
Minnesota
-377 Closed
CG
143
Cutler Group
California
$0 200 -290 -59%
HFM
144
Hartford Financial Management
Connecticut
-273 Closed
Walleye Trading
145
Walleye Trading
New York
-40 Closed
Fifth Third Bancorp
146
Fifth Third Bancorp
Ohio
-27 Closed
HT
147
HAP Trading
New York